Coronary collateral growth and its therapeutic application to coronary artery disease

Circulation Journal

Volumn 74, Issue 7, 2010, Pages 1283-1289

  Fujita, Masatoshi ^a   Sasayama, Shigetake ^b,c  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b DOSHISHA UNIVERSITY   (Japan)

^c Daijukai Hospital   (Japan)

Author keywords

Arteriogenesis; Coronary stenosis; Exercise; Myocardial ischemia; Shear stress

Indexed keywords

CYTOKINE; HEPARIN;

ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ANGIOGENESIS; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY DISEASE; COUNTERPULSATION; DISEASE MODEL; EXERCISE; HEART MUSCLE ISCHEMIA; HUMAN; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; SHEAR STRESS; STEM CELL TRANSPLANTATION; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION; ANIMAL; COLLATERAL CIRCULATION; DRUG EFFECTS;

ANIMALS; COLLATERAL CIRCULATION; CORONARY ARTERY DISEASE; HUMANS; MYOCARDIAL ISCHEMIA;

EID: 77954500587     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0376     Document Type: Article

References (70)

1. Helfant RH, Vokonas PS, Gorlin R. Functional importance of the human collateral circulation. N Engl J Med 1971; 284: 1277-1281.
2. Williams DO, Amsterdam EA, Miller RR, Mason DT. Functional significance of coronary collateral vessels in patients with acute myocardial infarction: Relation to pump performance, cardiogenic shock and survival. Am J Cardiol 1976; 37: 345-351.
3. Carroll RJ, Verani MS, Falsetti HL. The effect of collateral circulation on segmental left ventricular contraction. Circulation 1974; 50: 709-713.
4. Gregg DE, Patterson RE. Current concepts: Functional importance of the coronary collaterals. N Engl J Med 1980; 303: 1404-1406.
5. Schwartz H, Leiboff RL, Katz RJ, Wasserman AG, Bren GB, Varghese PJ, et al. Arteriographic predictors of spontaneous improvement in left ventricular function after myocardial infarction. Circulation 1985; 71: 466-472.
6. Habib GB, Heibig J, Forman SA, Brown BG, Roberts R, Terrin ML, et al. Influence of coronary collateral vessels on myocardial infarct size in humans: Results of phase I thrombolysis in myocardial infarction (TIMI) trial. Circulation 1991; 83: 739-746.
7. Sasayama S, Fujita M. Recent insights into collateral circulation. Circulation 1992; 85: 1197-1204.
8. Tanaka S, Yokoyama C, Kawamura I, Takasugi N, Kubota T, Ushikoshi H, et al. Conservative medication follow-up for over 20 years of a patient with ischemic heart disease after diagnosis of chronic total occlusion of the 3 main coronary arteries. Circ J 2008; 72: 1205-1209.
9. Schaper W, Buschmann I. Arteriogenesis, the good and bad of it. Eur Heart J 1999; 20: 1297-1299.
10. Fujita M, Tambara K. Recent insights into human coronary collateral development. Heart 2004; 90: 246-250.
11. Takeda Y, Uemura S, Iwama H, Imagawa K, Nishida T, Onoue K, et al. Treatment with recombinant placental growth factor (PIGF) enhances both angiogenesis and arteriogenesis and improves survival after myocardial infarction. Circ J 2009; 73: 1674-1682.
12. Pohl T, Seiler C, Billinger M, Herren E, Wustmann K, Mehta H, et al. Frequency distribution of collateral flow and factors influencing collateral channel development: Functional collateral channel measurement in 450 patients with coronary artery disease. J Am Coll Cardiol 2001; 38: 1872-1878.
13. Strauer BE, Brehm M, Zeus T, Kostering M, Hernandez A, Sorg RV, et al. Repair of infarcted myocardium by autologous intracoro-nary mononuclear bone marrow cell transplantation in humans. Circulation 2002; 106: 1913-1918.
14. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002; 106: 3009-3017.
15. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet 2004; 364: 141-148.
16. Lipinski MJ, Biondi-Zoccai GG, Abbate A, Khianey R, Sheiban I, Bartunek J, et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: A collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol 2007; 50: 1761-1767.
17. Ziegelhoeffer T, Fernandez B, Kostin S, Heil M, Voswinckel R, Helisch A, et al. Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ Res 2004; 94: 230-238.
18. Schaper W. Tangential wall stress as a molding force in the development of collateral vessels in the canine heart. Experientia 1967; 23: 595-596.
19. Scheel KW, Wilson JL, Ingram LA, McGehee L. The septal artery and its collaterals in dogs with and without circumflex occlusion. Am J Physiol 1980; 238: H501-H514.
20. Scheel KW, Williams SE. Hypertrophy and coronary and collateral vascularity in dogs and coronary and collateral vascularity in dogs with severe chronic anemia. Am J Physiol 1985; 249: H1031-H1037.
21. Franklin D, McKown D, McKown M, Hartley J, Caldwell M. Development and regression of coronary collaterals induced by repeated, reversible ischemia in dogs (abstract). Fed Proc 1981; 40: 339.
22. Yamamoto H, Tomoike H, Shimokawa H, Nabeyama S, Nakamura M. Development of collateral function with repetitive coronary occlusion in a canine model reduces myocardial reactive hyperemia in the absence of significant coronary stenosis. Circ Res 1984; 55: 623-632.
23. Fujita M, Mikuniya A, Takahashi M, Gaddis R, Hartley J, McKown D, et al. Acceleration of coronary collateral development by hepa-rin in conscious dogs. Jpn Circ J 1987; 51: 395-402.
24. Fujita M, McKown DP, McKown MD, Hartley J, Franklin D. Evaluation of coronary collateral development by regional myocardial function and reactive hyperaemia. Cardiovasc Res 1987; 21: 377-384.
25. Rugh KS, Garner HE, Hatfield DG, Miramonti JR. Ischaemia induced development of functional coronary collateral circulation in ponies. Cardiovasc Res 1987; 21: 730-736.
26. Fujita M, McKown DP, McKown MD, Franklin D. Electrocardio-graphic evaluation of collateral development in conscious dogs. J Electrocardiol 1988; 21: 55-64.
27. Fujita M, McKown DP, McKown MD, Franklin D. Effects of glyc-eryl trinitrate on functionally regressed newly developed collateral vessels in conscious dogs. Cardiovasc Res 1988; 22: 639-647.
28. Mohri M, Tomoike H, Noma M, Inoue T, Hisano K, Nakamura M. Duration of ischemia is vital for collateral development: Repeated brief coronary artery occlusions in conscious dogs. Circ Res 1989; 64: 287-296.
29. Fujita M, Sasayama S, Ohno A, Yamanishi K, Araie E, Franklin D. Importance of myocardial ischemia for coronary collateral development in conscious dogs. Int J Cardiol 1990; 27: 179-186.
30. Fujita M, McKown DP, McKown MD, Franklin D. Bidirectional function of coronary collateral circulation channels in conscious dogs. Cardiovasc Res 1991; 25: 58-67.
31. Kersten JR, Pagel PS, Warltier DC. Protamine inhibits coronary collateral development in a canine model of repetitive coronary occlusion. Am J Physiol 1995; 268: H720-H728.
32. Williams DO, Boatwright RB, Rugh KS, Ross CR, Sarazan RD, Garner HE, et al. Equine coronary hemodynamics during brief coronary occlusions at three levels of collateral function. Am J Physiol 1996; 270: H1893-H1904.
33. Matsunaga T, Warltier DC, Weihrauch DW, Moniz M, Tessmer J, Chilian WM. Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide. Circulation 2000; 102: 3098-3103.
34. Yamanishi K, Fujita M, Ohno A, Sasayama S. Importance of myo-cardial ischaemia for recruitment of coronary collateral circulation in dogs. Cardiovasc Res 1990; 24: 271-277.
35. Symons JD, Pitsillides KF, Longhurst JC. Chronic reduction of myocardial ischemia does not attenuate coronary collateral development in miniswine. Circulation 1992; 86: 660-671.
36. Hershey JC, Baskin EP, Glass JD, Hartman HA, Gilberto DB, Rogers IT, et al. Revascularization in the rabbit hindlimb: Dissociation between capillary sprouting and arteriogenesis. Cardiovasc Res 2001; 49: 618-625.
37. Pipp F, Boehm S, Cai WJ, Adili F, Ziegler B, Karanovic G, et al. Elevated fluid shear stress enhances postocclusive collateral artery growth and gene expression in the pig hind limb. Arterioscler Thromb Vasc Biol 2004; 24: 1664-1668.
38. Bourassa MG, Solignac A, Goulet C, Lesperance J. Regression and appearance of coronary collaterals in humans during life. Circulation 1974; 49/50(Suppl II): II-127-II-135.
39. Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985; 5: 587-592.
40. Fujita M, Sasayama S, Ohno A, Nakajima H, Asanoi H. Importance of angina for development of collateral circulation. Br Heart J 1987; 57: 139-143.
41. Wustmann K, Zbinden S, Windecker S, Meier B, Sailer C. Is there functional collateral flow during vascular occlusion in angiographically normal coronary arteries? Circulation 2003; 107: 2213-2220.
42. Fujita M, Nakae I, Kihara Y, Hasegawa K, Nohara R, Ueda K, et al. Determinants of collateral development in patients with acute myocardial infarction. Clin Cardiol 1999; 22: 595-599.
43. Rentrop KP, Thornton JC, Feit F, van Buskirk M. Determinants and protective potential of coronary arterial collaterals as assessed by an angioplasty model. Am J Cardiol 1988; 61: 677-684.
44. Pijls NH, van Son JA, Kirkeeide RL, De Bruyne B, Gould KL. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation 1993; 87: 1354-1367.
45. Seiler C, Fleisch M, Garachemani A, Meier B. Coronary collateral quantitation in patients with coronary artery disease using intravascular flow velocity or pressure measurements. J Am Coll Cardiol 1998; 32: 1272-1279.
46. Fujita M, Ikemoto M, Kishishita M, Otani H, Nohara R, Tanaka T, et al. Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina. Circulation 1996; 94: 610-613.
47. Panchal VR, Rehman J, Nguyen AT, Brown JW, Turrentine MW, Mahomed Y, et al. Reduced pericardial levels of endostatin correlate with collateral development in patients with ischemic heart disease. J Am Coll Cardiol 2004; 43: 1383-1387.
48. Schirmer SH, van Royen N, Moerland PD, Fledderus JO, Henriques JP, van der Schaaf RJ, et al. Local cytokine concentrations and oxygen pressure are related to maturation of the collateral circulation in humans. J Am Coll Cardiol 2009; 53: 2141-2147.
49. Arras M, Ito WD, Scholz D, Winkler B, Schaper J, Schaper W. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest 1998; 101: 40-50.
50. Grines CL, Watkins MW, Helmer G, Penny W, Brinker J, Marmur JD, et al. Angiogenic gene therapy (AGENT) trial in patients with stable angina pectoris. Circulation 2002; 105: 1291-1297.
51. Henry TD, Annex BH, McKendall GR, Azrin MA, Lopez JJ, Giordano FJ, et al. The VIVA trial: Vascular endothelial growth factor in Ischemia for vascular angiogenesis. Circulation 2003; 107: 1359-1365.
52. Ehsani AA, Heath GW, Hagberg JM, Sobel BE, Holloszy JO. Effects of 12 months of intense exercise training on ischemic ST-segment depression in patients with coronary artery disease. Circulation 1981; 64: 1116-1124.
53. Schuler G, Schlierf G, Wirth A, Mautner HP, Scheurlen H, Thumm M, et al. Low-fat diet and regular, supervised physical exercise in patients with symptomatic coronary artery disease: Reduction of stress-induced myocardial ischemia. Circulation 1988; 77: 172-181.
54. Todd IC, Bradnam MS, Cooke MB, Ballantyne D. Effects of daily high-intensity exercise on myocardial perfusion in angina pectoris. Am J Cardiol 1991; 68: 1593-1599.
55. Scheel KW, Ingram LA, Wilson JL. Effects of exercise on the coronary and collateral vasculature of beagles with and without coronary occlusion. Circ Res 1981; 48: 523-530.
56. Lawson WE, Hui JCK, Zheng ZS, Oster Z, Katz JP, Diggs P, et al. Three-year sustained benefit from enhanced external counterpulsation in chronic angina pectoris. Am J Cardiol 1995; 75: 840-841.
57. Arora RR, Chou TM, Jain D, Fleishman B, Grawford L, McKiernan T, et al. The multicenter study of enhanced external counterpulsa-tion (MUST-EECP): Effect of EECP on exercise-induced myocardial ischemia and anginal episodes. J Am Coll Cardiol 1999; 33: 1833-1840.
58. Flynn MS, Kern MJ, Donohou TJ, Aguirre FU, Bach RG, Caracciolo EA. Alterations of coronary collateral blood flow velocity during intraaortic balloon pumping. Am J Cardiol 1993; 71: 1451-1455.
59. Sackner MA, Gummels E, Adams JA. Nitric oxide is released into circulation with whole-body, periodic acceleration. Chest 2005; 127: 30-39.
60. Matsumoto T, Fujita M, Tarutani Y, Yamane T, Takashima H, Nakae I, et al. Whole-body periodic acceleration enhances brachial endothelial function. Circ J 2008; 72: 139-143
61. Bonetti PO, Barsness GW, Keelan PC, Schnell TI, Pumper GM, Kuvin JT, et al. Enhanced external counterpulsation improves endo-thelial function in patients with symptomatic coronary artery disease. J Am Coll Cardiol 2003; 41: 1761-1768.
62. Miyamoto S, Inoko M, Haruna T, Oba M, Uehara K, Nakane E, et al. Novel treatment with whole body periodic acceleration with a horizontal motion platform improves exercise capacity, myocardial ischemia and left ventricular function in intractable anginal patients. Eur Heart J 2009 (abstract: 439).
63. Taylor S, Folkman J. Protamine is an inhibitor of angiogenesis. Nature 1982; 297: 307-312.
64. Fujita M. Heparin and angiogenic therapy. Eur Heart J 2000; 21: 270-274.
65. Tateno S, Terai M, Niwa K, Jibiki T, Hamada H, Yasukawa K, et al. Alleviation of myocardial ischemia after Kawasaki disease by heparin and exercise therapy. Circulation 2001; 103: 2591-2597.
66. Masuda D, Fujita M, Nohara R, Matsumori A, Sasayama S. Improvement of oxygen metabolism in ischemic myocardium as a result of enhanced external counterpulsation with heparin pretreatment for patients with stable angina. Heart Vessels 2004; 19: 59-62.
67. Kosaki K, Ando J, Korenaga R, Kurokawa T, Kamiya A. Fluid shear stress increases the production of granulocyte-macrophage colony-stimulating factor by endothelial cells via mRNA stabilization. Circ Res 1998; 82: 794-802.
68. Buschmann IR, Hoefer IE, van Royen N, Katzer E, Braun-Dulleaus R, Heil M, et al. GM-CSF: A strong arteriogenic factor acting by amplification of monocyte function. Atherosclerosis 2001; 159: 343-356.
69. Seiler C, Pohl T, Wustmann K, Hutter D, Nicolet PA, Windecker S, et al. Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: A randomized, double-blind, placebo-controlled study. Circulation 2001; 104: 2012-2017.
70. Zbinden S, Zbinden R, Meier P, Windecker S, Seiler C. Safety and efficacy of subcutaneous-only granulocyte-macrophage colony stimulating factor for collateral growth promotion in patients with coronary artery disease. J Am Coll Cardiol 2005; 46: 1636-1642.